# John Wojcik

> John Wojcik works as Associate Vice President, Head Translational Biomarkers at Merck & Co Inc, recorded in ORCID since 2025. Their published research is indexed in Medicine, specifically Oncology, across 33 works listed on their ORCID profile. OpenAlex records an h-index of 17 and 1,513 citations across 64 indexed publications. Recent indexed output includes “2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in…” (2025) and “2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated…” (2025).

*Source: [https://selltoscientists.com/researchers/john-wojcik/](https://selltoscientists.com/researchers/john-wojcik/)*

**Institution:** Merck & Co Inc
**Field:** Medicine
**H-index:** 17
**Publications:** 64
**ORCID:** `0000-0001-5403-3631`

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product